Wong R L, Katz M E, Ogata K, Tan E M, Cohen S
Department of Pathology, University of Connecticut Health Center, Farmington 06032.
Cell Immunol. 1987 Dec;110(2):443-8. doi: 10.1016/0008-8749(87)90137-7.
Proliferating cell nuclear antigen (PCNA) is expressed in the nuclei of proliferating cells, but is not detected in resting cells. The kinetics of PCNA expression suggest that it is associated with a phase preceding active DNA synthesis. DNA synthesis is under cytoplasmic control, and there is a cytoplasmic protein, ADR (activator of DNA replication), that induces DNA synthesis in isolated quiescent nuclei. We now report that a human antibody preparation monospecific for PCNA, but not two monoclonal antibodies directed against different epitopes on PCNA, can inhibit the ability of ADR to induce DNA synthesis in isolated quiescent nuclei. This effect is not due to inhibition of DNA polymerase alpha activity. Thus, the anti-PCNA antibody exerts its effect either by directly influencing the initial interaction of ADR with the nucleus, or by inhibiting subsequent synthetic events.
增殖细胞核抗原(PCNA)在增殖细胞的细胞核中表达,但在静止细胞中未检测到。PCNA表达的动力学表明它与活跃DNA合成之前的一个阶段相关。DNA合成受细胞质控制,有一种细胞质蛋白ADR(DNA复制激活剂),它能在分离的静止细胞核中诱导DNA合成。我们现在报告,一种对PCNA具有单特异性的人抗体制剂,而不是两种针对PCNA不同表位的单克隆抗体,能够抑制ADR在分离的静止细胞核中诱导DNA合成的能力。这种效应不是由于抑制了DNA聚合酶α的活性。因此,抗PCNA抗体通过直接影响ADR与细胞核的初始相互作用,或通过抑制随后的合成事件来发挥其作用。